chrisvoncsefalvay/vaers-outcomes huggingface dataset:
7-8 drops of vaccine fell down arm when vaccine was given; A spontaneous report was received from a consumer concerning her 75-year old, mother who received Moderna's COVID-19 vaccine (mRNA-1273) resulting in the event, 7-8 drops of vaccine fell down the arm when the vaccine was given.  The patient's medical history was not provided. Concomitant medications were Levothyroxine sodium, Atorvastatin calcium and Acetylsalicylic acid.  On 20 Jan 2021, the patient received their first dose of two planned doses of mRNA-1273 (Lot Number: 013L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 20 Jan 2021, the patient received the mRNA-1273 vaccine and 7-8 drops of vaccine fell down the arm when the vaccine was given. As per the reporter, the vaccinating nurse stated that she believed that less than half of the dose was actually given.  No treatment for the event was provided.  Action taken with mRNA-1273 in response to the event was not reported.  The outcome of the event, 7-8 drops of vaccine fell down the arm when the vaccine was given was considered Resolved on 20 Jan 2021.; Reporter's Comments: This report refers to a case of incorrect dose administered for mRNA-1273.  There were no reported adverse events associated with this case.
Pt recvd vax 10FEB92 because had no antibodies to rubella; a few hrs following vax pt noted tongue was thick & itchy; burning of conjuctiva & light hurt eyes; acute rubella synd pinpoint rash, low grade temp & swollen glands; exp joint pain
Right arm pain less than 1 day after the shot Extreme tiredness 1 day after the shot Headache 3 days after the shot
All of the common side effects; Temperature is currently 101.1; This case was reported by a consumer via call center representative and described the occurrence of adverse reaction in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 13th November 2019, the patient received the 2nd dose of Shingrix. In November 2019, less than a week after receiving Shingrix, the patient experienced adverse reaction and fever. On an unknown date, the outcome of the adverse reaction and fever were unknown.   It was unknown if the reporter considered the adverse reaction and fever to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was considered as adult as per vaccine indication. The day before reporting at about 3:00, the patient received Shingrix. The patient experienced all of the common side effects. At the time of reporting, the patient's temperature was 101.1 degrees F. The patient asked how long would the side effects usually last. The patient would report the symptoms to the pharmacist and declined to provide any personal information.
09:48am While waiting her wait time, reading emails, she felt flushed, like a "hot flash". Heart rate per her apple watch was 152.  09:54am Seated, placed on monitor for BP and O2 sat., 151/90, HR 111, 99% on room air.  10:05 158/87, 111, 99% - RA 10:10 147/85, 102, 100% - RA, States feeling nervous.  10:20 144/84, 96, 100% - RA, States feeling better, less nervous. No shortness of breath, no facial swelling. No other complaints. Allowed to leave facility. With instructions to follow up with Emergency Department if any life threatening symptoms develop and to follow up with Employee Health if needed.  She verbalized understanding of above.
Skin just below vaccination site became red, firm, swollen and itchy 8-9 days after COVID vaccine. Suspect this is ?COVID arm? that I read about on the internet.
throat felt swollen but no dyspnea;hives on neck & in mouth;face puffy;no tx;
I got a Shingles shot, came down with Shingles/Suspected vaccination failure; Shingles in left arm; Shingles in right arm; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and shingles. On an unknown date, the outcome of the vaccination failure, shingles and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine. It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional Information: GSK Receipt Date: 01-SEP-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The reporter stated that, his/her sister came down with shingles, so he/she immediately went out and got a shingles shot in his/her right arm. Then he/she caught shingles on his/her right side. So, later, he/she got a new and improved shingles hot in his/her left arm. The patient came down with shingles on his/her left side. Additional Supportive Information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available. Note: As vaccine name was not specified so new and improved was considered shingles vaccine conservatively.
This spontaneous report as received from a pharmacist refers to two patients of unknown age and gender, who will be entering college in the fall. On an unknown date in 2014 ("recently") the patients were inadvertently vaccinated with a dose of LIQUID PEDVAXHIB (dosage, route and lot # not reported). No symptoms reported. The outcome of event was not reported. Additional information has been requested.
the patient has not had any side effects at this time; 3 year old patient was giving a GARDASIL 9 by accident it was suppose to be given to her 11 year old sister; 3 year old patient was giving a GARDASIL 9 by accident it was suppose to be given to her 11 year old sister; This spontaneous report was received from a registered nurse referring to a 3 year old female patient. The patient's pertinent medical history, concurrent conditions and concomitant medications were not provided.      On 14-DEC-2020, the patient was vaccinated, by accident, with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) for prophylaxis (strength, dose, route of administration, anatomical location, lot # and expiration were unknown) as it was supposed this vaccine should had been given to her 11 year old sister. However, patient had not had any side effects at reporting time but they would like to know if there was anything they need to look for or watch for.
sore arm; arm got red; This is a spontaneous report (letter response) received from a contactable consumer (patient). A patient of unspecified age and gender received first dose of (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL1284) via intramuscular in left arm on 15Jan2021 at 13:00 as a single dose for COVID-19 immunisation. The medical history was not reported. The patient concomitant medication was none. On 15Jan2021, the patient experienced sore arm, arm got red. The patient did not receive any treatment for the events. The outcome of the events was recovered on an unknown date in 2021.  Information on the lot/batch number has been requested.
Patient was observed post Covid-19 immunization for  30 minutes based on pre-vaccination screening .  During the observation period, she experienced an adverse reaction with the following symptoms: facial redness, c/o  being hot, also nausea and vomiting. Then she c/o left facial numbness and severe headache. RN noted during neuro assessment right facial droop, slurred speech, and left sided weakness. It was also noted that she had a right sided gaze deviation. DTR+3    Assessment : 1535  .facial redness, c/o  being hot, also nausea and vomiting. Then she c/o left facial numbness and severe headache. RN noted during neuro assessment right facial droop, slurred speech, and left sided weakness. It was also noted that she had a right sided gaze deviation.
Full rash from head to toe; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Full rash from head to toe) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Lupus erythematosus systemic.   On 13-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Full rash from head to toe). At the time of the report, RASH (Full rash from head to toe) outcome was unknown. Not Provided          Rash started after the first dose and developed full rash from head to toe after the second dose  Action taken with mRNA1273 Moderna vaccine was Not Applicable    This case was linked to MOD-2021-080207 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-080207:FIRST DOSE CASE
Had daily headaches after first dose of vaccine. For 3 weeks. Decided to skip the second dose because of that. Then had leg pain after nearly a month of the vaccine. Thought it was muscle pain but landed up in ER with shortness of breath and was diagnosed with DVT and large PE.
Positive with Covid-19, Hypoxemia, Coughing and shortness of breath
Patient was having trouble eating on 06/26/2020 then went to the ER 06/27/2020 and  the doctor found ulcers in the patients mouth and said it was from receiving vaccinations on 06/23/2020
she has developed a sore throat; coughing; headache; lost voice; This is a spontaneous report from a contactable consumer(patient) via medical information team. A 61-year-old female patient received second dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 11Apr2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 11Apr2021 at a single dose for COVID-19 immunization. The patient developed a sore throat, coughing, headache and lost voice on 19Apr2021. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Site of injection became painful, hot to touch, very red and swollen. Evaluated by Dr. as being an infection, Keflex prescribed 500mg tid x 10days.
Mother text me a picture of daughters arm around 7 pm on 10/29/15. Are is hard and has an area of redness the size was 3 inches by 4 inches. Daughter complained of area hurting and was very hot. This am (10/30/2015) mother sent picture and redness is lighter but is larger and arm has a darker center like a bruise. Daughter says arm does not hurt like last night.
I was very sick within hours of getting the vaccine. I was sneezing repeatedly, my nose was burning severely, my eyes were watering and burning.  I was wheezing and coughing.  I was too sick to get out of bed for about 24 hours.  It went away quickly and I was perfectly well after about 30 hours.  It was like I had been poisoned.  I am severely allergic to cats, mold, mushrooms, and rabbits.
Immediately after TD given, pt became very pale and nauseated. Assisted to lying position 10:10am BP 88/64, P 76. At 10:13 BP 88/64 P 76. At 10:22 BP 90/58 P 72. 10:32am BP 88/56 P 76 R 24. 10:38 sitting BP 90/64 P 72. 10:43 lying BP 100/74 P 72 R 20 sitting BP 10/84.
This spontaneous report as received from a physician via a field representative refers to a male patient of unknown age. In July 2013 the patient was vaccinated with a single dose of ZOSTAVAX (lot#, strength, dosage and route unknown). In January 2014, 6 months later, he was diagnosed with shingles. The patient had sought medical attention. The outcome of the event was unknown. Additional information has been requested.
Medical assistant mentioned that a patient mentioned to the physician regarding her neighbor's daughter who was vaccinated with a dose of GARDASIL. Concomitant therapy included MENACTRA. Subsequently the patient became paralyzed. Unknown medical attention was sought. The patient's outcome is unknown. No product quality complaint was involved. Upon internal review paralysis is considered to be an other important medical event. This is a hearsay report in the absence of an identifiable patient. Attempts are being made to verify the existence of a patient." Additional information has been requested.   7/10/08-records received -11/20/07-collapsed on floor of doctor office, hit head, alert oriented. 11/21/07-follow up phone call sutures in head, returning to school.
After I administered the vaccines when patient stood up he became faint and started to fall. I caught him and got him to a chair and then the floor with his feet up. He never lost consciousness. He was nervous about getting the vaccines, but actually did well and was surprised that it was done and he did not realize it. He did not eat this morning, so that probably contributed too. After laying on the floor for about 15 minutes with his feet elevated,  I helped him get to a chair and gave him orange juice and a breakfast bar. He stayed another 15 minutes and was feeling back to normal when he left.
Information has been received from a physician concerning a 11 year old male with a history of 2 liver transplants in his life, who in approximately 2005 "a couple of years ago" was vaccinated with a dose of VARIVAX. On approximately 17-JUL-2007 "a couple of days ago" the patient developed shingles and was hospitalized. At the time of this report the patient was still in the hospital and had not recovered. No product quality complaint was involved. Additional information has been requested.
Pt reports IZ given in Rt gluteal. Had reaction, redness, swelling 1/2 dollar size x 1/4 inch. Swollen glands - groin area and cervical. Pt went to ER. Antibiotics were given. Pt received B-12 also in R Gluteal. Swelling of site 8/27.
Evening following vaccine (ROTATEQ) administration rash noted around lips and face and had x1 large loose stool.  Rash worsened overnight -> arm, red blotches on face, tops of hands & feet.  Rash faded with administration of Benadryl.
On March 12, 2008 the patient received ANTHRAX (left arm), TYPHOID (right arm) and HEPATITIS A (right arm) vaccinations around 1300. The patient was well hydrated and had eaten lunch. Within about 60 minutes the patient stated that she was nauseated. She denied abdominal pain, vomiting or diarrhea. In the early evening the patient noted redness and swelling about 3 inches around the injection site of her left upper arm. She also noted that she had a temperature of 101 and a severe headache (8/10). The headache was severe (8/10) for 2 days; then it was more mild (4/10) for the next 5 days. The patient treated her symptoms with MOTRIN every 6 hours. The nausea and local reaction subsided after 3 days. The patient missed one day of work. On 11 April the patient received ANTHRAX (left arm) and HPV (right arm) vaccinations around 13:00. The patient was well hydrated and had eaten lunch. Within one hour the patient was nauseated. Within 2 hours the patient noted redness and swelling at the left injection site which eventually extended close to the elbow. The next morning the patient stated that she had a temperature of 105.0, abdominal pain and diarrhea. She went to the UCC where she was treated with IV fluids, TYLENOL and ice bath. The patient was discharged with a handwritten prescription for medication for pain and nausea. The patient was off from work for the next 3 days. She was much improved at that time. All symptoms subsided although the patient does not remember the exact time frame.
BODY ACHING; CHILLS; ARM SORENESS; SLIGHT HEADACHE TOWARDS THE BACK OF HEAD; FEVERISH; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, and expiry: UNKNOWN) dose was not reported, administered on 15-MAR-2021 14:30 on left arm for prophylactic vaccination. No concomitant medications were reported. On 16-MAR-2021, the subject experienced body aching. On 16-MAR-2021, the subject experienced chills. On 16-MAR-2021, the subject experienced arm soreness. On 16-MAR-2021, the subject experienced slight headache towards the back of head. On 16-MAR-2021, the subject experienced feverish. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 98.6 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from feverish, chills, arm soreness, body aching, and slight headache towards the back of head. This report was non-serious.
Pt received 3rd COVID booster (new bivalent Pfizer) and flu vaccine (unknown manufacturer) on 9/7/22. On 9/14/22, pt developed rash on left forehead. He presented to urgent care 9/17/22 with worsening vesicular burning rash in left CN V-1 dermatomal distribution. He was diagnosed with shingles and treated with Valtrex Rx. He has no prior history of shingles, and reports he had had the shingles vaccine in the past.
One day after the vaccine, feeling fatigued, feverish (99.5), headache Two days after the vaccine, feeling some SOB w exertion, chest heaviness Mild chest heaviness 3 days after, resolved by end of day.
tiredness; headache; muscle pain; feeling unwell; swollen lymph nodes; hives with pain in them; pain; I got Shingles; This is a spontaneous report from a contactable consumer (patient). A 60-year-old female patient received bnt162b2 (BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in right arm on 03Mar2021 13:15 (also reported 15Mar2021 13:30) (Batch/Lot Number: ENG198) (at the age of 60 years old) as 1st dose, single for COVID-19 immunisation. Medical history included stage 3 kidney disease and thyroid disorder. The patient was not pregnant at the time of vaccination. Facility where the most recent COVID-19 vaccine was administered was in doctor's office/urgent care. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was reported that patient had other medications received within 2 weeks of vaccination (unspecified). On 03Mar2021, the patient experienced tiredness, headache, muscle pain, feeling unwell, swollen lymph nodes, hives with pain in them, pain and she got shingles. The events resulted in doctor or other healthcare professional office/clinic visit. The treatment received for the adverse event included Valtrex, anti biotic and creme. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the event shingles was unknown; and not recovered outcome for the other events.  No follow-up attempts are needed. No further information is expected.
Injection site with a quarter sized red lump with pink extending out about .5 inch, tender to touch, warm. 11/1/04  Fading, lump less than a dime size. Follow up: site reaction on left arm.
Chills, muscle/joint aches/pains, fever, nausea, headache, and injection arm red, itching patch below injection site about 3? x 4? Took ibuprofen
Patient complaining of a temperature (102 degrees) and redness/swelling around the area the vaccine was given
Information has been received from a registered nurse (R.N.) concerning a 12-month-old male who on 04-MAY-2006 was vaccinated with a dose of Varivax (lot# 652804/0263F). There was no concomitant vaccinations. Subsequently, on an unspecified date, the patient developed a minimum of 50 pock marks, sought unspecified medical attention and was diagnosed with chickenpox. No outcome was reported. No product quality complaint was involved. Additional information has been requested.
11:50: pt received flu vaccine, IM LD, patient had never received a flu vaccine before, waited 15 min in waiting room prior to DC. Pt returned to clinic at 1400 stating blurred vision, neuro exam WNL, at 1410 pt stated vision changes had resolved, pt sent home, instructed to go to ER if symptoms reoccur or other symptoms occur.
01/01/21 presents to ED for "fatigue and chest discomfort". PMHx of "COPD on 3L, HFpEF, RLE DVT on Eliquis, OSA, SSS s/p PPM, T2DM, HTNN, hypothyroid, chronic HBV, BPD, obesity".
rash to inj site 4cm x 3cm but not raised in 15min time span;report to MD;DPH ordered & given;
COVID-19 vaccine ... fever 99.9, soreness at injection site, red welt at injection site, joint aches, headache, and fatigue lasted about 12 hours except for red welt, that lasted about 2 weeks.
Systemic: Autoimmune Disease (diagnosed by MD)-Mild, Systemic: VASCULITIS-Mild
I contracted Covid19 on 05/12/2022 with symptoms of post nasal drip, congestion, hoarse voice, sore throat, and myalgia. I received Monoclonal antibodies on 05/13/2022. I developed a sty in my eye due to allergies I believe. My symptoms are in the process of resolving as of today day 5 of illness.
Patient reports swelling of the tongue and lips more than 30 minutes after first dose of Moderna Covid vaccine on 5/13/21. She dis not seek medical care at the time.  Patient  insists on getting second dose which she received 6/10/21 with no observed adverse events.
Dose administered after 30-day Use By Date or after manufacturer date of expiry; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2022, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry). On 04-Feb-2022, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry) had resolved.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication was reported.  No Treatment medication was reported.  On 03 Feb 2022 at 15:00 PM initially vial was stored in the refrigerator. Vial did not went under temperature excursion. On 04 Feb 2022 expired vaccine was given to patient. HCP was wanted to know next steps for correcting, that if she could revaccinate the patient and wanted information regarding  validity of doses.
Gardasil - 1st inj 2/27/07 10-11 AM -03:00 pm could not breath, swallow - voice deep- hoarse. Did not go to ER - Fri AM took Benadryl, Baby ASA, throat spray. Lasted 2-3 days office today for 2nd inj told reaction after 1st inj.
1-2 Hours after vaccine given went Home with Nausea/dizziness Unproved next 2 days with Headache and abdominal pain and dizziness.